“Used in combination with genomics, AI could help pharma companies to develop new drugs for rare diseases. The rarer a disease is, the smaller the market is and so the less likely it is to have been addressed. Big pharma… — Ronald M. Razmi Copy Share Image
“It’s estimated that AI could free up to 25% of clinician time across different specialties. This increased amount of time could mean less hurried… — Ronald M. Razmi Copy Share Image
“Used in combination with genomics, AI could help pharma companies to develop new drugs for rare diseases. The rarer a disease is, the smaller… — Ronald M. Razmi Copy Share Image
“Cognitive robotics can integrate information from pre-operation medical records with real-time operating metrics to guide and enhance the precision of physicians’ instruments. By processing… — Ronald M. Razmi Copy Share Image
